UPDATE : Monday, September 7, 2020
상단여백
‘Flu vaccine VaxigripTetra fit for upcoming flu season’
Sanofi Pasteur Korea said its four-strain influenza vaccine VaxigripTetra, ...
by Nam Doo-hyun  |  2018-08-30 10:47
라인
‘Pharmaceutical stocks to bottom out soon’
Korean pharmaceutical and biotech shares are expected to have an upward tre...
by Nam Doo-hyun  |  2018-08-29 14:34
라인
Chong Kun Dang, Dongkook lead functional foods
Chong Kun Dang Healthcare, a subsidiary of Chong Kun Dang, topped the local...
by Nam Doo-hyun  |  2018-08-27 15:42
라인
‘Xeomin’s side effect lowest among 5 botulinum toxins’
Merz said its botulinum toxin product Xeomin showed the lowest level of ina...
by Nam Doo-hyun  |  2018-08-27 14:39
라인
Gilead’s Genvoya comfortably tops HIV treatments
Gilead Sciences Korea’s Genvoya has solidified its No. 1 status in the huma...
by Nam Doo-hyun  |  2018-08-24 14:33
라인
3 multinationals refuse to take pharma group’s anti-corruption system
GSK Korea, Janssen Korea and Astellas Pharma Korea refused to adopt ISO 370...
by Nam Doo-hyun  |  2018-08-23 12:01
라인
Foreign CEOs to lead Korean units of Novartis, Galderma
Novartis Korea and Galderma Korea will have new foreign CEOs next month.Nov...
by Nam Doo-hyun  |  2018-08-22 13:56
라인
[Special] Pharmaceuticals at odds with government over selective benefit system
The pharmaceutical industry is raising concerns over the government’s plan ...
by Nam Doo-hyun  |  2018-08-21 15:57
라인
Korea narrows gap with Japan in healthcare IoT patents
Korea is catching up with Japan in the Internet of Things (IoT) patents in ...
by Nam Doo-hyun  |  2018-08-16 15:52
라인
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
“Please insert ‘severe’ in front of ‘acute pancreatitis’ in the headline an...
by Nam Doo-hyun  |  2018-08-16 14:24
라인
Local patents increasingly target obesity
Amid forecasts that the obesity therapy market will rapidly grow, local res...
by Nam Doo-hyun  |  2018-08-14 16:26
라인
Who will be first to develop new acute pancreatitis remedy?
Korea’s Samsung Bioepis and Japan’s Takeda Pharmaceutical have teamed up to...
by Nam Doo-hyun  |  2018-08-14 10:32
라인
Bio stock slump drags down diagnostics, equipment, reagent companies
The shares of diagnostics, equipment, reagent and clinical agent companies ...
by Nam Doo-hyun  |  2018-08-09 14:29
라인
‘Bayer’s liver cancer drug better than expected’
Bayer Korea’s liver cancer therapy Stivarga (regorafenib) is expected to st...
by Nam Doo-hyun  |  2018-08-06 18:21
라인
2018-listed pharmaceutical, medical shares tank
With pharmaceutical and medical device stocks tumbling in Seoul, share pric...
by Nam Doo-hyun  |  2018-07-31 14:02
라인
Patent approved to predict chemotherapeutic effects for breast cancer patients
A new patent for predicting chemotherapeutic effects for patients with easi...
by Nam Doo-hyun  |  2018-07-27 11:50
라인
[Exclusive] Invossa patent expired in 6 European countries
Kolon Life Science has lost its substance patent for Invossa-K, a cell gene...
by Nam Doo-hyun  |  2018-07-26 11:16
라인
Which multinational drugmaker grew most rapidly in H1?
Daiichi Sankyo Korea achieved the most substantive sales growth among multi...
by Nam Doo-hyun  |  2018-07-25 11:52
라인
Will new patent help detect norovirus easily?
A new patent for checking antibody of norovirus is drawing attention, as th...
by Nam Doo-hyun  |  2018-07-05 17:24
라인
‘UCB Korea to keep pursuing patient value in neurology’
UCB Korea will undoubtedly lead the domestic epilepsy treatment market, its...
by Nam Doo-hyun  |  2018-07-04 14:37
여백
여백
여백
Back to Top